Swiss Medica Inc. Continues To Receive International Attention For O24 Fibromyalgia

TORONTO, ONTARIO -- (MARKET WIRE) -- 06/08/2006 -- Swiss Medica, Inc. (OTCBB: SWME) announced today that international recognition continues to grow for its patented, all natural and clinically tested product O24 Fibromyalgia, with official approval by the Fibromyalgia Support Group Surrey & Sussex in the United Kingdom.

Back to news